Erlotinib.
Herbst
Roy S
RS
University of Texas M. D. Anderson Cancer Center, TX, USA.
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D049109:Cell Proliferation / Q000187:drug effects; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D009154:Mutation; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D015996:Survival Rate
D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors